If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Strategic Review

14 Mar 2024 07:00

RNS Number : 7782G
Amati AIM VCT PLC
14 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICITON WHERE TO DO SO WOULD COSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THE JURISDICITON.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATON FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

14 March 2024

Amati AIM VCT plc

 

Strategic review

 

The Board of Amati AIM VCT plc (the "Company") confirms that it has, in conjunction with the Company's investment manager, Amati Global Investors Limited (the "Investment Manager"), been considering the Company's strategic options in the light of ongoing challenges in the AIM market and the resultant performance issues faced by the Company. As part of this review, the Board intends to consider whether the Company's investment strategy should be expanded to facilitate investment in a broader range of securities while continuing to comply with the rules applicable to VCTs. 

 

The Board also notes the recent announcement of a recommended offer (the "Offer") for Mattioli Woods plc by Tiger Bidco Limited (owned by funds managed by Pollen Street Capital Limited). Mattioli Woods plc currently owns 49% of the issued share capital of the Investment Manager. The ongoing review of strategic options will take into account any possible impact of the Offer on the Company and the management of its investment portfolio.

 

Further details of the strategic review will be included in the Company's annual report and accounts which are expected to be published shortly.

 

Enquiries:

 

Fiona Wollocombe, Chair

Amati AIM VCT plc

Email: info@amatiglobal.com

 

Douglas Armstrong

Dickson Minto Advisers

Financial Adviser to the Company

Telephone: 020 7649 6823

 

Important Information

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.

Legal Entity Identifier (LEI): 213800HAEDBBK9RWCD25

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFMFUDELSEID
Date   Source Headline
15th Aug 201910:55 amRNSDirector/PDMR Shareholding
12th Aug 201912:08 pmRNSNet Asset Value(s)
9th Aug 201910:20 amRNSTransaction in Own Shares
5th Aug 20197:00 amRNSHolding(s) in Company
2nd Aug 20194:21 pmRNSTransaction in Own Shares
1st Aug 20194:57 pmRNSNet Asset Value(s)
1st Aug 20198:17 amRNSTotal Voting Rights
30th Jul 20193:18 pmRNSHolding(s) in Company
30th Jul 20192:58 pmRNSTransaction in Own Shares
26th Jul 20194:18 pmRNSIssue of Equity
26th Jul 20192:18 pmRNSNet Asset Value(s)
24th Jul 20192:17 pmRNSTransaction in Own Shares
19th Jul 20194:01 pmRNSNet Asset Value(s)
15th Jul 20194:58 pmRNSNet Asset Value(s)
11th Jul 20195:11 pmRNSTransaction in Own Shares
8th Jul 201910:25 amRNSNet Asset Value(s)
4th Jul 201911:54 amRNSTransaction in Own Shares
2nd Jul 201911:19 amRNSNet Asset Value(s)
1st Jul 20198:17 amRNSTotal Voting Rights
26th Jun 20198:00 amRNSIntention to launch an offer for subscription
24th Jun 201911:43 amRNSNet Asset Value(s)
14th Jun 20195:29 pmRNSNet Asset Value(s)
7th Jun 20193:14 pmRNSNet Asset Value(s)
6th Jun 20193:44 pmRNSHolding(s) in Company
4th Jun 20192:49 pmRNSTransaction in Own Shares
4th Jun 201910:55 amRNSNet Asset Value(s)
3rd Jun 20198:14 amRNSTotal Voting Rights
28th May 20192:58 pmRNSDirector/PDMR Shareholding
28th May 20192:55 pmRNSNet Asset Value(s)
22nd May 20192:09 pmRNSTransaction in Own Shares
20th May 20198:11 amRNSNet Asset Value(s)
20th May 20198:06 amRNSHolding(s) in Company
13th May 20195:10 pmRNSTransaction in Own Shares
10th May 20195:24 pmRNSNet Asset Value(s)
9th May 20195:49 pmRNSHolding(s) in Company
7th May 20193:24 pmRNSTransaction in Own Shares
2nd May 201912:16 pmRNSTransaction in Own Shares
2nd May 201910:46 amRNSNet Asset Value(s)
1st May 20198:21 amRNSTotal Voting Rights
26th Apr 20195:25 pmRNSNet Asset Value(s)
26th Apr 201911:47 amRNSTransaction in Own Shares
23rd Apr 201912:35 pmRNSNet Asset Value(s)
17th Apr 20194:29 pmRNSTransaction in Own Shares
17th Apr 201910:01 amRNSDividend Declaration
17th Apr 20199:55 amRNSAnnual Financial Report
15th Apr 201912:15 pmRNSNet Asset Value(s)
11th Apr 201912:15 pmRNSTransaction in Own Shares
8th Apr 20192:41 pmRNSIssue of Equity
5th Apr 20194:16 pmRNSNet Asset Value(s)
5th Apr 20191:04 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.